Acute Nonlymphocytic Leukemia Completed Phase 3 Trials for Guaifenesin (DB00874)

Also known as: Nonlymphocytic Leukemias, Acute / Acute myeloid leukemia / Leukemia, Myeloid, Acute / Acute myelocytic leukaemia / Acute myelocytic leukemia / Acute myeloblastic leukemia with failed remission / Leukaemia myeloblastic acute / AML / Non-lymphoblastic leukaemia acute / Non-lymphoblastic leukemia acute / Acute myeloid leukemia NOS / Myeloid leukaemia, acute / Leukaemias acute myeloid / Acute myeloblastic leukemia / Acute myeloblastic leukaemia / Leukemia myeloblastic acute / Acute granulocytic leukaemia / Acute granulocytic leukemia / Acute myeloid leukaemia / Myeloid leukemia, acute / Acute myeloid leukaemia NOS

IndicationStatusPhase
DBCOND0048632 (Acute Nonlymphocytic Leukemia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01191801Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AMLTreatment